Bendamustine Kabi

Bendamustine Kabi Indications/Uses

bendamustine

Manufacturer:

Fresenius Kabi

Distributor:

Zuellig Pharma
Full Prescribing Info
Indications/Uses
CLL: Indicated for the treatment of patients with chronic lymphocytic leukaemia.
NHL: Relapsed/Refractory indolent Non-Hodgkin's lymphoma.
Previously untreated NHL: Previously untreated indolent CD20-positive, stage III-IV Non-Hodgkin's lymphoma, in combination with rituximab.
Previously untreated MCL: Previously untreated CD20-positive, stage III-IV Mantle Cell Lymphoma in combination with rituximab, in patients ineligible for autologous stem cell transplantation.
Sign up for Free to continue reading
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in